Robert G. Schmelzer
Plus aucun poste en cours
Profil
Robert G.
Schmelzer is Vice President of Operation and General Manager of WELLS-CTI, Inc. and Vice President and General Manager of Antares Advanced Test Technologies, Inc. Previously, he was Vice President of Tyco Electronics Ltd.
Mr. Schmelzer held various positions at Air Products & Chemicals, Inc., Penwest Pharmaceuticals Co. and PA Power & Light.
Anciens postes connus de Robert G. Schmelzer
| Sociétés | Poste | Fin |
|---|---|---|
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Corporate Officer/Principal | - |
| AIR PRODUCTS & CHEMICALS, INC. | Corporate Officer/Principal | - |
Antares Advanced Test Technologies, Inc.
 Antares Advanced Test Technologies, Inc. SemiconductorsElectronic Technology Antares Advanced Test Technologies is reducing the cost of semiconductor test, with concentration on high-sensitivity areas like yield and integration of test disciplines, by focusing on customer support, delivering innovative technologies and offering a single point of contact for semiconductor ATE test cell requirements as well as burn-in and thermal management solutions. The industry is demanding technology advances that are focused on reducing the cost of test. As a technology-based company, Antares Advanced Test Technologies is committed to delivering innovative, cost-effective test solutions that are timely, smarter and dedicated to reducing the cost of test, specifically in areas can make a significant impact. The company thoroughly understands the requirements and demands of interfacing and interconnecting. | Corporate Officer/Principal | - |
| TE CONNECTIVITY LTD. | Corporate Officer/Principal | - |
WELLS-CTI, Inc.
 WELLS-CTI, Inc. Industrial MachineryProducer Manufacturing WELLS-CTI, Inc. designs and manufactures semiconductor test equipment. The company was founded in July, 1948 and is headquartered in Phoenix, AZ. | Directeur des opérations | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TE CONNECTIVITY LTD. | Electronic Technology |
| AIR PRODUCTS & CHEMICALS, INC. | Process Industries |
| Entreprise privées | 3 |
|---|---|
WELLS-CTI, Inc.
WELLS-CTI, Inc. Industrial MachineryProducer Manufacturing WELLS-CTI, Inc. designs and manufactures semiconductor test equipment. The company was founded in July, 1948 and is headquartered in Phoenix, AZ. | Producer Manufacturing |
Antares Advanced Test Technologies, Inc.
Antares Advanced Test Technologies, Inc. SemiconductorsElectronic Technology Antares Advanced Test Technologies is reducing the cost of semiconductor test, with concentration on high-sensitivity areas like yield and integration of test disciplines, by focusing on customer support, delivering innovative technologies and offering a single point of contact for semiconductor ATE test cell requirements as well as burn-in and thermal management solutions. The industry is demanding technology advances that are focused on reducing the cost of test. As a technology-based company, Antares Advanced Test Technologies is committed to delivering innovative, cost-effective test solutions that are timely, smarter and dedicated to reducing the cost of test, specifically in areas can make a significant impact. The company thoroughly understands the requirements and demands of interfacing and interconnecting. | Electronic Technology |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
